Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction-# Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash TransactionShare---Divestiture streamlines operations and advances the Company's strategy to fully exit non-core activitiesLOS ANGELES--([BUSINESS WIRE])-- [Niagen Bioscience, Inc.](NASDAQ: NAGE), the global authority on NAD+ (nicotin ...